1-6 of 6
Vito Michele Lauta
Close
Sort by
Journal Articles

A Prospective, Randomized, Phase III Study of Melphalan 200 mg/m 2 (Mel200) Versus Melphalan 100 mg/m 2 (Mel100) in Newly Diagnosed Myeloma Patients.

Antonio Palumbo, MD, Sara Bringhen, MD, Maria Teresa Petrucci, MD, Antonietta Falcone, MD, Anna Marina Liberati, MD, Vito Michele Lauta, MD, Mariella Grasso, MD, Marco Montanaro, MD, Francesco Pisani, MD, Tommaso Caravita, MD, Clotilde Cangialosi, MD, Patrizia Pregno, MD, Andrea Nozza, MD, Elisabetta Calabrese, MD, Francesca Gay, MD, Federica Cavallo, MD, Paola Omedè, BSc, Pellegrino Musto, MD, Robin Foà, MD, Mario Boccadoro, MD
Journal: Blood
Blood (2007) 110 (11): 727.
https://doi.org/10.1182/blood.V110.11.727.727
Published: 2007
Journal Articles

Superiority of Double over Single Autologous Stem-Cell Transplantation for Newly Diagnosed Multiple Myeloma and Prognostic Impact of Complete Response: Final Analysis of “Bologna 96” Study.

Michele Cavo, MD, Giulia Perrone, M.D., Michela Ceccolini, M.D., Vito Michele Lauta, M.D., Massimo Offidani, M.D., Filippo Ballerini, M.D., Lucia Pantani, M.D., Annamaria Brioli, M.D., Silvana Pasini, M.D., Fausto Dore, M.D., Domenico Vertone, M.D., Paola Tacchetti, M.D., Elena Zamagni, M.D., Patrizia Tosi, M.D., Sante Tura, M.D., Michele Baccarani, M.D.
Journal: Blood
Blood (2007) 110 (11): 730.
https://doi.org/10.1182/blood.V110.11.730.730
Published: 2007
Journal Articles

A Prospective Randomized Trial of Oral Melphalan, Prednisone, Thalidomide (MPT) vs Oral Melphalan, Prednisone (MP): An Interim Analysis.

Antonio Palumbo, MD, Alessandra Bertola, MD, Pellegrino Musto, MD, Tommaso Caravita, MD, Vincenzo Callea, MD, Clotilde Cangialosi, MD, Anna Marina Liberati, MD, Pasquale Niscola, MD, Lucio Catalano, MD, Mariella Grasso, MD, Vito Michele Lauta, MD, Maria Concetta Petti, MD, Sergio Morandi, MD, Monica Galli, MD, Sara Bringhen, MD, Federica Cavallo, MD, Patrizia Falco, MD, Mario Boccadoro, MD
Journal: Blood
Blood (2004) 104 (11): 207.
https://doi.org/10.1182/blood.V104.11.207.207
Published: 2004
Journal Articles

Intermediate-dose melphalan improves survival of myeloma patients aged 50 to 70: results of a randomized controlled trial

Clinical Trials & Observations
Antonio Palumbo, Sara Bringhen, Maria Teresa Petrucci, Pellegrino Musto, Fausto Rossini, Martina Nunzi, Vito Michele Lauta, Cesare Bergonzi, Anna Barbui, Tommaso Caravita, Antonio Capaldi, Patrizia Pregno, Tommasina Guglielmelli, Mariella Grasso, Vincenzo Callea, Alessandra Bertola, Federica Cavallo, Patrizia Falco, Cecilia Rus, Massimo Massaia, Franco Mandelli, Angelo Michele Carella, Enrico Pogliani, Anna Marina Liberati, Franco Dammacco, Giovannino Ciccone, Mario Boccadoro
Journal: Blood
Blood (2004) 104 (10): 3052–3057.
https://doi.org/10.1182/blood-2004-02-0408
Published: 2004
Journal Articles

Elderly Aggressive-Histology Non-Hodgkin’s Lymphoma: First-Line VNCOP-B Regimen Experience on 350 Patients

Pier Luigi Zinzani, Sergio Storti, Alfonso Zaccaria, Luciano Moretti, Massimo Magagnoli, Enzo Pavone, Patrizia Gentilini, Luciano Guardigni, Marco Gobbi, Pier Paolo Fattori, Brunangelo Falini, Vito Michele Lauta, Maurizio Bendandi, Filippo Gherlinzoni, Amalia De Renzo, Francesco Zaja, Patrizio Mazza, Ettore Volpe, Monica Bocchia, Enrico Aitini, Maurizio Tabanelli, Giuseppe Leone, Sante Tura
Journal: Blood
Blood (1999) 94 (1): 33–38.
https://doi.org/10.1182/blood.V94.1.33.413k08_33_38
Published: 1999
Journal Articles

Randomized Trial With or Without Granulocyte Colony-Stimulating Factor as Adjunct to Induction VNCOP-B Treatment of Elderly High-Grade Non-Hodgkin's Lymphoma

Pier Luigi Zinzani, Enzo Pavone, Sergio Storti, Luciano Moretti, Pier Paolo Fattori, Luciano Guardigni, Brunangelo Falini, Marco Gobbi, Patrizia Gentilini, Vito Michele Lauta, Maurizio Bendandi, Filippo Gherlinzoni, Massimo Magagnoli, Stefamia Venturi, Enrico Aitini, Maurizio Tabanelli, Giuseppe Leone, Vincenzo Liso, Sante Tura
Journal: Blood
Blood (1997) 89 (11): 3974–3979.
https://doi.org/10.1182/blood.V89.11.3974
Published: 1997